Search

Your search keyword '"Lu, Junyan"' showing total 441 results

Search Constraints

Start Over You searched for: Author "Lu, Junyan" Remove constraint Author: "Lu, Junyan" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
441 results on '"Lu, Junyan"'

Search Results

2. Detect influential points of feature rankings

4. IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening

5. Dual biological role and clinical impact of de novo chromatin activation in chronic lymphocytic leukemia

6. Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial

12. A Modified BiSeNet for Spinal Segmentation

14. Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progression

17. A Modified BiSeNet for Spinal Segmentation

20. Proteogenomics refines the molecular classification of chronic lymphocytic leukemia

21. Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape

24. The protein landscape of chronic lymphocytic leukemia

29. Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia

30. Urodynamic analysis of the effect of electroacupuncture at different acupoints on the bladder after spinal cord injury.

31. Revisiting the diagnostic and prognostic significance of high-frequency QRS analysis in cardiovascular diseases: a comprehensive review.

32. Leadership Reconfiguration in State-Acquired Privately Owned Enterprises: A Paradox between Institutional Control and Agency.

33. Construct prognostic models of multiple myeloma with pathway information incorporated.

34. Changes in Spatiotemporal Pattern and Its Driving Factors of Suburban Forest Defoliating Pest Disasters.

35. Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL

38. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome

40. Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia

41. Supplementary Data from PRMT1 Inhibition Activates the Interferon Pathway to Potentiate Antitumor Immunity and Enhance Checkpoint Blockade Efficacy in Melanoma

42. Data from PRMT1 Inhibition Activates the Interferon Pathway to Potentiate Antitumor Immunity and Enhance Checkpoint Blockade Efficacy in Melanoma

44. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

47. PRMT1 inhibition activates the interferon pathway to potentiate antitumor immunity and enhance checkpoint blockade efficacy in melanoma

50. IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms

Catalog

Books, media, physical & digital resources